GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	3.09B
Revenue (ttm)	2.81B
Net Income (ttm)	119.55M
Shares Out	83.51M
EPS (ttm)	1.43
PE Ratio	25.85
Forward PE	n/a
Dividend	0.75 (2.03%)
Ex-Dividend Date	Jul 18, 2024

Volume	35,977
Average Volume	24,074
Open	37.98
Previous Close	37.98
Day's Range	37.05 - 38.29
52-Week Range	24.70 - 47.30
Beta	0.93
RSI	42.60
Earnings Date	Mar 3, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is headquartered in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2023, GlaxoSmithKline S.A.E's revenue was 2.24 billion, an increase of 22.87% compared to the previous year's 1.82 billion. Earnings were 60.46 million, a decrease of -91.78%.